Tuesday, December 22, 2009

Bookkeeping: Beginning Human Genome Sciences (HGSI) Position

TweetThis
As complacency washes over me, I am beginning a 2.1% stake in Human Genome Sciences (HGSI) as the stock crosses the $30 threshold; this stock was highlighted late yesterday.  This is a buy completely for technical reasons, as the chart is almost a direct mirror of the S&P 500... a very long base, from which the assumption is a breakout shall ensue.  Stop loss will be placed slightly below the blue line (20 day moving average) although $27 has been a good floor during the base building of November & December.  If the stock starts breaking out i.e. $31+, I'll add more.

EDIT 12:35 PM - I added more exposure in mid $30's, as the computers have picked up what I have flagged... the stock looks strong.  Will add more on a break over $31.




Please note my comments from yesterday ;)


Let me offer a word of warning; I stay away from biotech stocks as a rule since they are mostly lottery tickets unless you are talking some of the huge names like Amgen (AMGN) or Gilead (GILD) for example. I will generally make a foray into biotech every 12-18 months when I get very overconfidant, the market is "way too easy" (as it is now - just buy almost anything and you'll make money sooner or later), or I'm just plain bored and want some spice in the portfolio. Within a short period of my biotech purchase, invariably either the stock crashes or the market does. ;) So as I am pondering this name, take that into consideration.


Long Human Genome Sciences in fund; no personal position

Disclaimer: The opinions listed on this blog are for educational purpose only. You should do your own research before making any decisions.
This blog, its affiliates, partners or authors are not responsible or liable for any misstatements and/or losses you might sustain from the content provided.

Copyright @2012 FundMyMutualFund.com